Beyond Medical Technologies Inc.
DOCT
CNSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.17% | -17.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.17% | -17.50% | |||
| Operating Income | -0.17% | 17.50% | |||
| Income Before Tax | 62.52% | 18.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 62.52% | 18.07% | |||
| Earnings from Discontinued Operations | -- | -100.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 62.52% | 17.96% | |||
| EBIT | -0.17% | 17.50% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 80.26% | 18.28% | |||
| Normalized Basic EPS | 42.86% | 15.52% | |||
| EPS Diluted | 80.26% | 18.28% | |||
| Normalized Diluted EPS | 42.86% | 15.52% | |||
| Average Basic Shares Outstanding | 91.03% | 0.00% | |||
| Average Diluted Shares Outstanding | 91.03% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||